Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83K Sell
2,425
-545,949
-100% -$16.4M ﹤0.01% 2853
2026
Q1
$15.2M Buy
548,374
+8,028
+1% +$255K ﹤0.01% 1001
2025
Q4
$17.5M Sell
540,346
-50,806
-9% -$1.49M ﹤0.01% 896
2025
Q3
$16.9M Sell
591,152
-378,043
-39% -$11.4M ﹤0.01% 888
2025
Q2
$28.8M Buy
969,195
+276,723
+40% +$8.62M 0.01% 901
2025
Q1
$23M Sell
692,472
-236,743
-25% -$8.41M 0.01% 901
2024
Q4
$31.8M Buy
929,215
+296,198
+47% +$11.1M 0.01% 788
2024
Q3
$22.9M Buy
633,017
+381,488
+152% +$13.4M 0.01% 894
2024
Q2
$8.59M Sell
251,529
-109,950
-30% -$3.76M ﹤0.01% 1205
2024
Q1
$12.4M Sell
361,479
-34,836
-9% -$1.14M ﹤0.01% 929
2023
Q4
$13.5M Sell
396,315
-24,462
-6% -$733K 0.01% 892
2023
Q3
$11.3M Buy
420,777
+7,153
+2% +$210K 0.01% 917
2023
Q2
$12.5M Hold
413,624
0.01% 886
2023
Q1
$12.5M Buy
413,624
+14,848
+4% +$427K 0.01% 886
2022
Q4
$10.2M Buy
398,776
+6,083
+2% +$150K 0.01% 929
2022
Q3
$8.27M Sell
392,693
-13,203
-3% -$325K ﹤0.01% 1027
2022
Q2
$8.97M Buy
405,896
+41,179
+11% +$1.05M ﹤0.01% 993
2022
Q1
$8.96M Buy
364,717
+6,316
+2% +$177K ﹤0.01% 1111
2021
Q4
$11.9M Sell
358,401
-390,283
-52% -$12.4M ﹤0.01% 1062
2021
Q3
$21.9M Sell
748,684
-201,553
-21% -$6.03M 0.01% 842
2021
Q2
$29M Sell
950,237
-677,486
-42% -$21.4M 0.01% 789
2021
Q1
$48.1M Buy
1,627,723
+632,391
+64% +$18.1M 0.02% 628
2020
Q4
$28.4M Buy
995,332
+83,087
+9% +$2.26M 0.01% 756
2020
Q3
$20.2M Sell
912,245
-12,456
-1% -$289K 0.01% 756
2020
Q2
$20.9M Sell
924,701
-20,079
-2% -$411K 0.01% 724
2020
Q1
$16.3M Buy
944,780
+150,603
+19% +$3.85M 0.01% 728
2019
Q4
$24.1M Buy
794,177
+71,503
+10% +$2.11M 0.01% 723
2019
Q3
$21.8M Sell
722,674
-22,539
-3% -$665K 0.01% 742
2019
Q2
$22.2M Buy
745,213
+6,915
+0.9% +$183K 0.02% 734
2019
Q1
$18.6M Buy
738,298
+4,507
+0.6% +$116K 0.01% 761
2018
Q4
$17.2M Buy
733,791
+67,313
+10% +$1.67M 0.01% 736
2018
Q3
$19.4M Sell
666,478
-22,256
-3% -$668K 0.01% 762
2018
Q2
$20.9M Buy
688,734
+6,415
+0.9% +$201K 0.02% 756
2018
Q1
$20.6M Buy
682,319
+6,545
+1% +$205K 0.02% 756
2017
Q4
$21.9M Buy
675,774
+17,987
+3% +$570K 0.02% 716
2017
Q3
$19M Buy
657,787
+32,114
+5% +$971K 0.02% 738
2017
Q2
$20M Buy
625,673
+53,007
+9% +$1.69M 0.02% 742
2017
Q1
$18.4M Buy
572,666
+96,878
+20% +$2.88M 0.02% 742
2016
Q4
$12.9M Buy
475,788
+34,591
+8% +$910K 0.01% 808
2016
Q3
$12.5M Buy
441,197
+100,754
+30% +$2.82M 0.01% 834
2016
Q2
$9.03M Buy
340,443
+66,701
+24% +$1.89M 0.01% 898
2016
Q1
$7.99M Buy
273,742
+3,530
+1% +$89.8K 0.01% 898
2015
Q4
$7.2M Sell
270,212
-26,642
-9% -$744K 0.01% 949
2015
Q3
$7.52M Buy
296,854
+136,889
+86% +$4.07M 0.01% 940
2015
Q2
$5.29M Buy
+159,965
New +$5.28M 0.01% 1040

Other funds holding AXTA

UBS AM's AXTA Position: Q2 2026 in Review

UBS AM reduced its Axalta (AXTA) stake by 100% in Q2 2026, selling an estimated $16.4M and leaving 2,425 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #2853.

UBS AM first reported a position in AXTA in Q2 2015 and has held it in 45 quarters since. The position peaked at $48.1M in Q1 2021. 359 funds tracked by Wall St. Rank hold AXTA as of Q2 2026.

  • UBS AM held 2,425 shares of Axalta worth $83K as of Q2 2026.
  • UBS AM sold 545,949 Axalta shares in Q2 2026, an estimated $16.4M.
  • Axalta made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2853 holding.
  • UBS AM first reported a position in Axalta in Q2 2015 and has held it in 45 quarters since.
  • UBS AM's Axalta position peaked at $48.1M in Q1 2021.
  • 359 funds tracked by Wall St. Rank held Axalta as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.